Efficacy of intrapleural streptokinase use in complicated parapneumonic pleural effusions and empyema

G. Okumus, S. Karaosman, E. Kiyan, H. Issever, O. Arseven (Istanbul, Turkey)

Source: Annual Congress 2008 - Pleural effusion
Session: Pleural effusion
Session type: Oral Presentation
Number: 4566
Disease area: Respiratory infections, Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Okumus, S. Karaosman, E. Kiyan, H. Issever, O. Arseven (Istanbul, Turkey). Efficacy of intrapleural streptokinase use in complicated parapneumonic pleural effusions and empyema. Eur Respir J 2008; 32: Suppl. 52, 4566

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Intrapleural tenectaplase therapy in treatment of loculated parapneumonic pleural effusions and empyema
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015

Intrapleural streptokinase in the management of loculated pleural fluids of various aetiologies
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010

Intrapleural streptokinase treatment of complicated parapneumonic effusions and empyemas
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013


Parapneumonic effusion and empyema
Source: Respipedia Article
Year: 2017

Treatment of parapneumonic pleural effusion and empyema: conservative view
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=199
Year: 2004

Respiratory functional status after intrapleural t-PA administration for complicated parapneumonic effusions
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012

Update on the management of parapneumonic pleural effusions
Source: Virtual Congress 2021 – Spanish/Portuguese programme 2021
Year: 2021


Treatment results of patients with complicated parapneumonic effusion and empyema
Source: Eur Respir J 2002; 20: Suppl. 38, 358s
Year: 2002

Prognostic features of residual pleural thickening in parapneumonic pleural effusions
Source: Eur Respir J 2003; 21: 952-955
Year: 2003



Management of parapneumonic effusion and empyema in children
Source: Eur Respir J 2002; 20: Suppl. 38, 589s
Year: 2002

Pneumothorax and urokinase for pleural empyema in children
Source: Eur Respir J 2001; 18: Suppl. 33, 170s
Year: 2001

The effect of intrapleural fibrinolytic therapy in the drainage of loculated haemorrhagic effusions
Source: Eur Respir J 2001; 18: Suppl. 33, 387s
Year: 2001

Efficacy of rapid pleurodesis in malignat pleural effusions
Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Year: 2010

Intrapleural streptokinase for empyema and complicated parapneumonic effusions: a randomised controlled trial
Source: Annual Congress 2004 - New diagnostic and therapeutic applications in bronchoscopy and thoracoscopy
Year: 2004


Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions
Source: Eur Respir J 2002; 19: 320-325
Year: 2002



Intrapleural perfusion hyperthermo-chemotherapy for malignant pleural effusion
Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases
Year: 2009

Predictors of outcome in parapneumonic pleural effusions in children
Source: Eur Respir J 2001; 18: Suppl. 33, 171s
Year: 2001